Irprestan Hct Actavis Group (Hydrochlorothiazide, Irbesartan)

Irbesartan blocks the angiotensin II type 1 (AT1) receptor, preventing vasoconstriction and aldosterone‑mediated sodium retention. Hydrochlorothiazide inhibits sodium‑chloride reabsorption in the distal convoluted tubule, increasing urine output and decreasing plasma volume. Together they lower systemic vascular resistance and blood pressure.

The appropriate dose of Irprestan Hct is determined by the prescribing healthcare professional based on the patient’s medical condition, response to therapy, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Hydrochlorothiazide / Irbesartan in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Irprestan Hct, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Irprestan Hct combines an angiotensin II receptor blocker with a thiazide diuretic, offering dual mechanisms that can be more effective than monotherapy for some patients. Compared with ACE inhibitors or calcium‑channel blockers, the combination may provide better blood‑pressure control with a single pill, but individual response varies.

Irprestan Hct should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Irprestan Hct is taken orally, usually once daily, with or without food, as directed by the prescribing clinician. Swallow the tablet whole with a full glass of water; do not crush or chew unless specifically instructed.

Serious risks include severe allergic reactions such as angioedema, significant drops in blood pressure, and kidney function impairment. Patients should seek immediate medical attention if they experience swelling of the face or throat, faintness, or sudden changes in urine output.

Individuals with known hypersensitivity to irbesartan, hydrochlorothiazide, or any component of the formulation should avoid the product. It is also contraindicated in patients with severe renal or hepatic impairment, and caution is advised in pregnancy, lactation, and those taking interacting medications.